Huber Needles Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027


Posted December 9, 2020 by SANJAYCMI

Huber Needles Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
Huber needles are available in two different types, namely straight Huber needles and curved Huber needles. Curved Huber needles have 90 degree angle, which are used in long term access; however, straight Huber needles are used for short access. These needles are used for different application such as dialysis, chemotherapy, blood transfusion, and others. Huber needles are effective alternatives to other infusion delivery systems.

Statistics:

The global Huber Needles Market is estimated to account for US$ 66.1 Mn in terms of value and 51,270,030 Units in terms of volume by the end of 2027.

Global Huber Needles Market: Drivers

Stringent government regulations regarding use of safety needles to avoid hospital-acquired diseases such as HIV, Hepatitis C, and Hepatitis B are expected to propel growth of the global Huber needles market over the forecast period. For instance, the Needlestick Safety and Prevention Act was passed in the U.S. in 2000. The act focuses on providing nurses or medical staff with information related to additional protection while using needles, in order to reduce occupational exposure to blood borne pathogens.

Global Huber Needles Market: Restraints

Product recalls due to technical issues with Huber needles are expected to hinder growth of the global Huber needles market. Various medical grade materials are used to manufacture Huber needle and safety products. In the recent past, use of Huber needles was believed to lead possible risk of silicon contamination. Thus, companies had to recall their products in bulk in order to reduce further risk of contamination.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/huber-needles-market-3648

Key Takeaways:

The Curved Huber Needles segment in the global Huber needles market was valued at US$ 32.3 Mn in 2019 and is expected to reach US$ 53.4 Mn by 2027 at a CAGR of 6.5% during the forecast period. Increasing incidence and prevalence cancer is expected to boost growth of the segment during the forecast period.

The IV Cancer Application segment held dominant position in the global Huber needles market in 2019, accounting for 41.7% share in terms of value, followed by dialysis, respectively. The growth of the segment is attributed to increasing demand for Huber needles and increasing adoption of expansion strategies from manufacturers operating in the market to increase product portfolio and geographical positioning.

Market Trends

Increasing prevalence of end-stage renal disease is expected to boost growth of the global Huber needles market. For instance, according to November 2019 data of National Center for Biotechnology Information, the prevalence of end-stage renal disease is rising at a stable number of about 20,000 cases per year.

Major players in the market are focused on adopting various marketing strategies to expand their customer base. For instance, in February 2020, Baxter International Inc. presented at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3648

Regulations

Europe

European Union (EU) mandates the design and quality assurance test in order to maintain the safety guideline

EU categorized Huber needle under Class III device, which requires EC verification and quality assurance for marketing and commercialization

Global Huber Needles Market: Competitive Landscape

Major players operating in the global Huber Needles market include, Baxter International Inc., B. Braun Medical Inc., Smiths Medical, NIPRO Medical Corporation, AngioDynamics, Inc., and C. R. Bard, Inc.
Global Huber Needles Market: Key Developments

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2018, Smiths Medical launched a new distribution model for non-hospital-based infusion customers that simplifies the way providers order, receive and deliver care with CADD infusion therapy products.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3648

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags huber needles market growth , huber needles market outlook , huber needles market size
Last Updated December 9, 2020